You are currently viewing a new version of our website. To view the old version click .

Gastrointestinal Cancers: Molecular Mechanisms and Therapies

Special Issue Information

Dear Colleagues,

This Special Issue on “Gastrointestinal Cancers: Molecular Mechanisms and Therapies” will mainly focus on analyzing present and future approaches for the treatment of gastrointestinal cancer patients, with a glimpse of novel perspectives and future challenges in clinical practice. Gastrointestinal cancers are one of the most common worldwide cause of cancer-related death. In the last decade, significant improvements have been made in the prognosis of patients with gastrointestinal cancers deriving from the development of modern tailored therapies, which include cytotoxic drugs, targeted therapies, and immunotherapy. Recently, emerging and novel biomarkers have been identified and validated with a huge impact on patients’ outcomes and improving the treatment landscape. Despite these advances, gastrointestinal cancers still represent a major public health problem worldwide; hence, it is mandatory to develop novel therapeutic approaches for patients affected by those cancers. We cordially invite experts in the field to submit original research or review articles pertaining to this important and fast-progressing field of biomedicine.

Dr. Seok-Jun Kim
Dr. Valentina Calò
Guest Editors
Dr. Marta Castiglia
Dr. Nadia Barraco
Co-Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular biomarker
  • colon cancer
  • gastric cancer
  • pancreatic cancer
  • genetics
  • therapeutic targets
  • precision medicine
  • tumor microenvironment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059Creative Common CC BY license